National Institutes of Health
Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)
Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional) is a funding opportunity from National Institutes of Health, closing January 28, 2028.
Jan 28, 2028
(546d left)Overview
The purpose of this announcement is to encourage investigators to pursue translational activities and clinical feasibility studies to advance the development of therapeutic, and diagnostic devices for disorders that affect the nervous or neuromuscular systems. Activities supported in this program include…